# Nutrace — AI Build Log

> This document is a transparent, public record of how Nutrace was built using AI agent systems. Every session is logged here — what was asked, what was decided, what was produced, and what the AI contributed vs. what the human decided.
>
> The goal is not to hide the AI's role. The goal is to show **how a Senior TPM uses AI as a force multiplier** — making faster, better-evidenced decisions while maintaining full human judgment on strategy, scope, and direction.

---

## Why this document exists

Building in public means showing your work — including the tools you used. The rise of AI-assisted product development raises a fair question: *what does the human actually contribute?*

This log answers that. Every session shows:
- **What Alex brought:** Context, judgment calls, strategic decisions, scope control
- **What the AI contributed:** Research synthesis, document drafting, structured analysis, pattern matching
- **What got decided:** The decision itself, who made it, and why

This is not a "look, AI did my work" story. It's a "here's how a modern TPM works" story.

---

## System Architecture

Nutrace is being built using a **6-agent AI system** running on Claude (Anthropic), operated through Cowork mode on the Claude desktop app. Each agent has a defined role, a structured response format, and a set of GitHub artifacts they are responsible for producing.

| Agent | Role | Analogy |
|-------|------|---------|
| Chief of Staff | Session orchestration, sequencing, scope control | Engineering Manager / TPM |
| Founder | Market thesis, GO/NO-GO, risk framing | Investor / Founder lens |
| CPO | Product discovery, ICP, PRD, hypotheses | Head of Product |
| CTO | Architecture, stack decisions, implementation plan | Tech Lead |
| CDO | UX flows, wireframes, user tasks | UX Lead |
| CMO | Positioning, messaging, GTM, LinkedIn | Head of Marketing |

The human (Alex) orchestrates the agents, provides context, makes all strategic decisions, validates outputs, and decides what gets committed to GitHub.

**Key principle:** The AI drafts and researches. The human decides and commits.

---

## Session Log

---

### Session 001 — 2026-02-28

**Duration:** ~90 minutes
**Phase:** A — Ideation / Selection
**Agents activated:** Chief of Staff, Founder, CMO, CPO (naming only)

#### What Alex brought to the session

- Core idea: frictionless food + symptom diary for people with digestive problems
- Key UX hypothesis: photos + voice instead of manual forms
- Context: AI vision models and Whisper are now accessible enough to build this solo
- Three strategic questions: Who is the user (wellness vs. clinical)? Which professional? How complex is the MVP?

#### What the AI was asked to do

1. Research the digestive health market to validate whether the pain is real and growing
2. Analyze the competitive landscape of existing gut health / IBS tracking apps
3. Run the Founder Scorecard (10-criterion framework, 1–5 per criterion)
4. Identify why the idea could fail (honest risk framing)
5. Facilitate a naming debate between CMO and CPO agents
6. Produce the two founding documents for the repo

#### What the AI produced

- Market research synthesis from 7 primary sources (PubMed, AGA, Healio, Nature, Grand View Research)
- Competitive analysis of 7 existing apps (Cara Care, mySymptoms, Bowelle, Nerva, myIBS, IBS Coach, FODMAP A to Z)
- Founder Scorecard: **43/50 → GO**
- Risk analysis: 4 risks identified and framed (adoption sustainability, professional trust, AI accuracy, regulatory)
- Naming debate: CMO vs CPO, 5 candidates evaluated, consensus on **Nutrace**
- `docs/00-project-charter.md` — full project definition
- `docs/01-founder-venture-brief.md` — full Founder brief with sources
- `CLAUDE.md` — project memory file for future sessions
- `docs/ai-build-log.md` — this file

#### What Alex decided (human judgment calls)

| Decision | Options considered | What Alex chose | Why |
|----------|-------------------|-----------------|-----|
| ICP: diagnosis stage | Wellness optimizer / Suspected diagnosis / Confirmed diagnosis | **Suspected or in-diagnosis** | More urgent pain; professional loop more relevant |
| Professionals in loop | Only gastroenterologist / Only dietitian / Both | **Both** | Different use cases, both valid early adopters |
| MVP complexity | Patient + professional dashboard / Patient only + PDF | **Patient only + PDF** | 10x simpler to build; validates core hypotheses first |
| Name | GutLog / Gutsy / PatternLog / Trazr / Nutrace | **Nutrace** | International, clean, describes the action |

#### What got committed to GitHub

```
feat: init nutrace project — Founder GO decision with competitive research and market validation

- docs/00-project-charter.md
- docs/01-founder-venture-brief.md
- CLAUDE.md
- docs/ai-build-log.md
- README.md
- src/, assets/ (structure)
```

#### Key insight from this session

The competitive gap is not that no apps exist — it's that **all existing apps are manual food diaries with analytics bolted on**. None have solved the friction problem with AI-native capture. The hypothesis is that photo + voice is the unlock. That hypothesis needs empirical validation before building.

#### Next step

Validate H1 (friction) and H2 (professional value) before CPO writes PRD-Lite. Target: 3 user conversations + 1 professional conversation within 5 days.

---

### Session 002 — 2026-03-01

**Duration:** ~120 minutes
**Phase:** B — Validation
**Agents activated:** Chief of Staff, CPO, CDO

#### 002 — What Alex brought

- Informal pre-validation: Alex had already tested H1 with his partner and himself, and spoken with a nutritionist to sense-check H2
- Request for rigorous structured validation via simulated interviews
- Decision after Round 2 to add a new user segment: patient with prior diagnosis + period of remission + symptom recurrence (Segment F)
- Feedback on the README "What Nutrace Does" table: add the proactive trigger alert feature

#### 002 — What the AI was asked to do

1. Round 1: CPO + CDO **generate synthetic interviews** — 15 user personas + 15 clinical expert personas — to stress-test H1 and H2 against plausible behavioral patterns
2. Round 2 (more rigorous): CPO + CDO pre-define hypotheses (VU, VC, BV), build a 12-question standardized script per cohort, generate 15 new synthetic user + 15 new synthetic clinical interviews in hypothesis → question → answer format, produce a formal H1/H2 report and user/clinical segmentation
3. Add Segment F to the segmentation based on Alex's **real-user observation** (not from synthetic interviews)
4. Update README to reflect proactive trigger alert and Phase B completion
5. Write and push `docs/03-validation-plan-and-results.md` to GitHub
6. Update all context files (CLAUDE.md, MEMORY.md, ai-build-log.md)

> ⚠️ **Methodology note:** All 60 interviews across Round 1 and Round 2 were **AI-generated (synthetic)**. They were not conducted with real people. They were used to stress-test hypotheses and surface edge cases before committing to architecture. Real-user validation (Alex + partner for H1, nutritionist conversation for H2, Segment F from direct observation) provided the grounding. See the [Research methodology note](#research-methodology-note-synthetic-interviews--real-user-validation) section below for full context.

#### 002 — What the AI produced

- Round 1: 30 **synthetic** interview simulations (15 user + 15 clinical), H1/H2 summary reports
- Round 2: Hypothesis framework (VU1–6, VC1–5, BV1–3), uncertainty × importance prioritization matrix, two standardized 12-question scripts, 30 new **synthetic** interviews in structured format
- H1 report: PASS (14/15 synthetic personas), 5 key design implications — grounded by real-user validation
- H2 report: PASS (15/15 synthetic personas), 5 key design implications — grounded by real nutritionist conversation
- User segmentation: 6 segments (A–F); Segment F added from real-world observation
- Clinical segmentation: 6 segments (P1–P6)
- `docs/03-validation-plan-and-results.md` — full validation record (pushed to GitHub)
- README updated: proactive trigger alert added, Phase B marked complete
- All context files updated (CLAUDE.md, AI Product Builder CLAUDE.md, MEMORY.md)

#### 002 — What Alex decided (human judgment calls)

| Decision | Options considered | What Alex chose | Why |
| --- | --- | --- | --- |
| Second round rigor | Continue with Round 1 / run more rigorous Round 2 | **More rigorous Round 2** | Round 1 lacked standardized scripts and formal segmentation |
| Segment F | Merge with Segment C / standalone segment | **Standalone Segment F** | Tripartite clinical question (relapse / new condition / misdiagnosis) is distinct enough |
| Proactive trigger alert | Keep as V2 / include in MVP | **Include in MVP** | Changes the core value prop — from passive diary to active risk-awareness tool |
| Voice input | Required per entry / optional | **Optional** | Social/work contexts make voice impractical; confirmed across multiple user personas |

#### 002 — What got committed to GitHub

```text
feat: add Phase B validation results — H1 + H2 passed, 6 user segments + 6 clinical segments
- docs/03-validation-plan-and-results.md

docs: update README — proactive trigger alert, Phase B complete, add validation doc link
- README.md
```

#### 002 — Key insight

**H1 confirmed, but the capture model is more flexible than assumed.** Photo is the anchoring behavior (everyone will do it); voice is the enhancement (many won't in public contexts). The proactive trigger alert — firing at the photo-capture step, powered by learned patterns — transforms Nutrace from a passive diary into a preventive tool. That's a materially stronger value proposition.

**H2 confirmed unanimously in Round 2.** The critical requirement that emerged: professionals want a symptom severity indicator in the PDF (traffic light or 1–5 scale). Without it the export is a log, not a clinical instrument.

#### 002 — Next step

Phase C — Definition. CPO writes `docs/04-prd-lite.md` incorporating all Phase B findings, 6 user segments, 6 clinical segments, and the 10 key build implications from `docs/03-validation-plan-and-results.md` Section 11.

---

### Session 003 — 2026-03-01

**Duration:** ~30 minutes
**Phase:** C — Definition
**Agents activated:** Chief of Staff, CPO

#### 003 — What Alex brought

- Phase B complete and fully pushed to GitHub (docs/03, README, CLAUDE.md)
- All context files updated and in sync
- Signal to proceed to Phase C — Definition

#### 003 — What the AI was asked to do

1. Read `docs/03-validation-plan-and-results.md` in full to ground the PRD-Lite in Phase B findings
2. Write `docs/04-prd-lite.md` — the minimum viable PRD to unblock CDO (UX flows) and CTO (architecture)
3. Update `docs/ai-build-log.md` with Session 003
4. Push both files to GitHub

#### 003 — What the AI produced

- `docs/04-prd-lite.md` — CPO PRD-Lite covering:
  - Problem statement (grounded in Phase B data)
  - Product vision sentence
  - ICP, 6 user segments (A–F) with Segment F detail, 6 clinical segments (P1–P6) as PDF-recipient profiles
  - 6 Jobs to Be Done (JTBD-01 through JTBD-06)
  - MVP feature set: capture (photo + voice, voice optional), proactive trigger alert, pattern view, PDF export (with traffic light severity + disclaimer), onboarding (eating disorder screen + Segment F context field)
  - Out-of-scope table (15 features explicitly excluded)
  - 10 hard design constraints from Phase B (for CDO + CTO)
  - 6 required user flows at functional level
  - Success metrics: North Star (7-day retention ≥40%), 7 measurable KPIs
  - Regulatory framing section with MDR/FDA scope note
  - Risk register (5 risks) and open questions (6 OQs)
  - Handoff checklist for CDO and CTO

#### 003 — What Alex decided (human judgment calls)

No new strategic decisions made this session — all scope, constraints, and segments were locked in Phase B. CPO applied Phase B findings faithfully.

#### 003 — What got committed to GitHub

```text
feat: Phase C — CPO PRD-Lite (docs/04-prd-lite.md)

All Phase B findings incorporated: 6 user segments, 6 clinical segments,
10 design constraints, 6 user flows, success metrics, regulatory framing.
Unblocks CDO (docs/05) and CTO (docs/06).

- docs/04-prd-lite.md
- docs/ai-build-log.md (Session 003)
```

#### 003 — Key insight

The PRD-Lite is intentionally scoped to what the CDO and CTO need — no more. Flows are defined functionally (what must happen), not visually (how it looks). Design constraints from Phase B are treated as hard constraints, not guidelines, to prevent them being lost in translation between product → design → engineering.

#### 003 — Next step

CDO reads `docs/04-prd-lite.md` and produces `docs/05-ux-flows-and-wireframes.md`, covering all 6 flows, all 6 user segments, and all design constraints from Section 7.

---

### Session 004 — 2026-03-02

**Duration:** ~120 minutes
**Phase:** C — Definition
**Agents activated:** Chief of Staff, CDO, CPO (review), CMO (agent-system doc)

#### 004 — What Alex brought

- Phase C PRD-Lite committed and complete (`docs/04-prd-lite.md`)
- Request to document the 6-agent AI system publicly (`docs/agent-system.md`)
- Request for CDO to produce the full UX flows and wireframes document
- Request for FigJam flow navigation diagrams (6 flows)
- Request for Figma Make prompts to generate low-fidelity wireframes
- Request for a CPO+CDO review and correction of all 6 flows and prompts
- Request to save all session state and update all context files

#### 004 — What the AI was asked to do

1. Write `docs/agent-system.md` — public-facing document explaining the 6-agent architecture
2. CDO produces `docs/05-ux-flows-and-wireframes.md` — all 6 flows, 18+ screens, ASCII wireframes, segment UX notes, constraint compliance checklist, CTO handoff questions
3. Create 6 FigJam navigation diagrams (one per flow) — showing all screens, decision points, and navigation paths
4. Write 6 Figma Make prompts for low-fidelity wireframe generation (one per flow)
5. CPO + CDO formal validation review of all 6 flows and prompts — flag and correct any misalignments with PRD-Lite and UX spec
6. Save all artifacts to `assets/user-flows/` and `assets/wireframes/` in the repo
7. Update all context files (ai-build-log, CLAUDE.md, MEMORY.md)

#### 004 — What the AI produced

- `docs/agent-system.md` — 6-agent architecture doc: roles, collaboration patterns, phase activation, artifact ownership, memory architecture, transparency statement
- `docs/05-ux-flows-and-wireframes.md` — CDO full spec: 6 flows, 18+ screens with ASCII wireframes, interaction specs, segment-specific UX notes per all 6 segments, 10-constraint compliance checklist, CTO handoff questions
- 6 FigJam navigation diagrams (live in FigJam, linked from repo):
  - Flow 1 — Onboarding (7 screens + advisory branch)
  - Flow 2 — Meal Log Entry (5 screens + 2 states)
  - Flow 3 — Delayed Symptom Check-in (notification + 1 screen)
  - Flow 4 — Pattern View (3 screens + ingredient toggle)
  - Flow 5 — PDF Export (2 screens)
  - Flow 6 — Trigger Alert Detail (1 screen, 3 exit paths)
- `assets/user-flows/README.md` — index of 6 FigJam links with flow descriptions and constraint coverage notes
- `assets/wireframes/README.md` — 6 corrected Figma Make prompts (all screens per flow), CPO+CDO validation notes, FigJam links, placeholder Figma wireframe links

**CPO+CDO review corrections applied (6 flows, 10 corrections):**

| Flow | Correction |
|------|-----------|
| Flow 1 | Added "You can turn this off any time" to notification permission copy (Screen 1.6) |
| Flow 2 | Both CTAs on confirmation screen (2.5) now specified as equal visual weight |
| Flow 3 | Added 2h and 4h notification variants as separate wireframe frames. Added dynamic meal name reference in Screen 3.1 |
| Flow 4 | Added empty state (Screen 4.0, 0 entries) — retention-critical missing screen. Added "tap to filter" interaction to ingredient view. Added bottom tab bar to all main screens |
| Flow 5 | Added empty state (Screen 5.0, no data). Added Segment F prior condition field in PDF preview |
| Flow 6 | Explicit constraint added: counts only ("X of Y meals"), no percentages, no statistical language — regulatory requirement |

**FigJam corrections flagged for manual edit (4 items):**
- Flow 2: rename node "Trigger Check" → "Ingredient Review + Trigger Alert"
- Flow 3: add note that both 2h/4h notifications render same screen with dynamic copy
- Flow 4: add empty state (0 entries) node before <3 days state
- Flow 5: add empty state node as initial entry point

#### 004 — What Alex decided (human judgment calls)

| Decision | Options considered | What Alex chose | Why |
|----------|-------------------|-----------------|-----|
| Visual validation approach | Full Figma wireframes now / FigJam flows + Figma Make prompts | **FigJam flows + Figma Make prompts** | FigJam MCP creates live diagrams immediately; Figma Make prompts let Alex control wireframe generation on personal account |
| Account for FigJam diagrams | Personal account (alex.almagir) / Work account (alex.maravilla) | **Work account** (MCP limitation — cannot switch accounts) | FigJam diagrams created on AiFi account; Alex to duplicate to personal |
| Wireframes folder structure | All in `docs/` / Separate `assets/wireframes/` folder | **`assets/wireframes/`** | Keeps design assets separate from documentation |

#### 004 — What got committed to GitHub

```text
docs: add agent system transparency document
- docs/agent-system.md

feat: Phase C CDO — UX flows and wireframes spec (docs/05)
- docs/05-ux-flows-and-wireframes.md

docs: add user flow diagrams index — 6 FigJam flows (Phase C CDO)
- assets/user-flows/README.md

docs: add wireframes folder with corrected Figma Make prompts
- assets/wireframes/README.md
- docs/ai-build-log.md (Session 004)
- CLAUDE.md (updated status and next steps)
```

#### 004 — Key insight

**The CPO+CDO review caught 10 corrections across 6 flows that would have created friction in wireframe generation** — the most critical being: (1) empty states were missing entirely from Flows 4 and 5 (retention-critical screens), (2) Flow 6 lacked an explicit regulatory constraint on data display format, and (3) Flow 3 only covered the 2h notification variant. The formal review step proves its value even in an agentic system — agent outputs benefit from agent cross-review before committing artifacts.

**The Figma MCP limitation is real but manageable:** the official Figma MCP can read designs and create FigJam flow diagrams, but cannot create Figma design files or wireframes. Figma Make prompts bridge this gap — they're the artifact that converts CDO spec into visual output, with the human (Alex) controlling the actual generation on his personal account.

#### 004 — Next step

Phase D — Build. Chief of Staff activates CTO.

CTO reads:
- `docs/04-prd-lite.md` — CPO PRD-Lite (especially Section 7: hard constraints + Section 8: functional flows)
- `docs/05-ux-flows-and-wireframes.md` — CDO full spec (especially the Handoff to CTO section: 6 open questions)

CTO produces:
- `docs/06-tech-architecture.md` — stack decisions, data model, AI integration choices, infra approach
- `docs/07-implementation-plan.md` — phased build plan, milestones, week-by-week breakdown

---

<!-- TEMPLATE FOR FUTURE SESSIONS — copy and fill in

### Session 00N — YYYY-MM-DD

**Duration:**
**Phase:**
**Agents activated:**

#### What Alex brought to the session

#### What the AI was asked to do

#### What the AI produced

#### What Alex decided (human judgment calls)

| Decision | Options considered | What Alex chose | Why |
|----------|-------------------|-----------------|-----|

#### What got committed to GitHub

#### Key insight from this session

#### Next step

-->

---

## Principles guiding AI use in this project

**1. Evidence over opinions.** Every market claim in this repo links to a source. If the AI can't find a source, the claim doesn't go in.

**2. Human decisions, AI drafts.** The AI produces options and structured analysis. Alex makes the call. The log above shows every place where a human judgment call was made.

**3. Scope discipline enforced by Chief of Staff.** The AI agent system includes a Chief of Staff whose explicit job is to prevent scope creep and force artifact production. Every session must end with a commit.

**4. Transparent about AI contribution.** This document exists because the honest answer to "how much did AI help?" is "a lot" — and that's fine. The question isn't how much AI helped. It's whether the judgment, direction, and decisions were sound.

**5. Builder signal, not hype.** Every artifact in this repo is real work, not a slide deck. The AI helped produce it faster and with more research depth than one person could do alone — but it's all here, readable, and verifiable.

---

## Research methodology note: synthetic interviews + real-user validation

This section documents a deliberate methodological choice made in Phase B (Validation) that is important to understand clearly.

### What happened

The 30 structured interviews described in Session 002 — 15 user personas and 15 clinical personas — were **generated by AI (Claude), not conducted with real people**. The AI simulated plausible interview responses based on: established UX research on food diary abandonment, published literature on IBS/functional GI disorder patient behavior, known clinical workflows for gastroenterologists and registered dietitians, and the hypothesis framework defined by the CPO agent.

This is called **synthetic user research** — a technique increasingly used in early-stage product discovery to stress-test hypotheses before committing to full research cycles.

### Why this choice was made

At Phase A→B, the goal is not to achieve statistical significance. It is to identify whether hypotheses are *obviously wrong* before investing in architecture and code. Synthetic interviews are well-suited for this because they surface logical gaps, missing edge cases, and under-specified user segments at very low cost and in hours rather than weeks.

The risk is that AI-generated personas reflect biases in training data and may miss non-obvious behavioral patterns.

### How the risk was mitigated

The synthetic research was **validated against real users** before any product decisions were locked. Specifically:

- Alex personally tested H1 (friction hypothesis) with himself and his partner over 5 days
- Alex had a direct conversation with a nutritionist to sense-check H2 (clinical value hypothesis)
- The addition of **Segment F** (prior diagnosis + relapse) came from Alex's direct real-world observation, not from the synthetic interviews — demonstrating that real-world input meaningfully shaped the output

The synthetic interviews provided the structure and breadth. Real-world signals provided the grounding and the edge cases that AI missed.

### What this means for the findings

The conclusions in `docs/03-validation-plan-and-results.md` should be read as **validated hypotheses, not as statistically significant research findings**. They are strong enough to justify proceeding to Phase C (Definition) and building an MVP. They are not sufficient to make claims about market size, conversion rates, or retention.

Full qualitative research (real interviews, session recordings) is planned for Phase D (Build) and beyond, once a working prototype exists to test.

### Why this is documented here

Transparency about methodology is non-negotiable in a public build. Hiding that interviews were AI-generated would undermine the credibility of everything else in this repo. Documenting it clearly — including how the risk was mitigated — is the correct way to use this technique responsibly.

This is also consistent with the broader positioning of this project: demonstrating how a senior PM uses AI as a force multiplier without substituting human judgment on what matters.
